The Hourly View for PFE
Last Updated February 19, 2021, 12:58 GMT
Currently, PFE’s price is down $-0.2 (-0.59%) from the hour prior. This move is a reversal from the hour prior, which saw price move up. Regarding the trend, note that the strongest trend exists on the 50 hour timeframe. The moving averages on the hourly timeframe suggest a choppiness in price, as the are all in a mixed alignment — meaning the trend across timeframes is inconsistent, indicating a potential opportunity for rangebound traders.
Pfizer Inc Daily Price Recap
The back and forth price flow continues for Pfizer Inc, which started today off at 34.56 US dollars, down 0.95% ($0.33) from the previous day. This move happened on lower volume, as yesterday’s volume was down 9.36% from the day before — and down 24.11% from the same day the week before. Below is a daily price chart of Pfizer Inc.
Pfizer Inc Technical Analysis
Volatility for Pfizer Inc has been contracting over the past two weeks relative to volatility over the past month. Whether volatility reverts will be something to watch. The clearest trend exists on the 30 day timeframe, which shows price moving down over that time. For additional context, note that price has gone down 17 out of the past 30 days.
Overheard Around the Web
Over on StockTwits, here’s an example of what they’re saying about PFE:
$IMNM I would think you're sitting on the cusp of something pretty special with IMNM. The Dept of Defense contract news with IMNM clearly states that their antibody research and discoveries have the capability of an "already in the can" vaccine to ANY future infectious disease outbreaks of any kind, as well as, an immediate vaccine to ALL the SARS Covid variants including brazil.
For me, that puts them miles ahead of the curve over $NVAX $MRNA $PFE etal. It's a shame there's only about 5 million shares available to the tutes that want to load up.
I'd hate for them to have to pay $300 for them. And that would be a bargain from these $30's. The market cap would still only be $3 billion compared to NVAX at $18 billion